CAF-secreted PAI-1 activates the AKT and MAPK pathways in a paracrine way to reduce chemotherapy drug-induced DNA damage, ROS generation, and cell death in esophageal squamous cell carcinoma (ESCC) (Che et al., 2018). Here, SERPINE1 is linked to esophageal squamous cell carcinoma.